Related Experiment Video
Updated: Aug 3, 2026
10:10
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
Published on: October 27, 2009
Platelet aggregation in patients treated with diflunisal
Current Medical Research and Opinion
|January 1, 1980
Summary
Diflunisal effectively relieves pain without impacting platelet function or causing bleeding. This non-steroidal analgesic is safe for patients experiencing musculoskeletal pain and other painful conditions.
Area of Science:
- Pharmacology
- Rheumatology
- Hematology
Background:
- Non-steroidal analgesics are widely used for pain relief.
- Potential effects on platelet function and bleeding risk require careful evaluation.
- Diflunisal is a non-steroidal analgesic prescribed for various painful conditions.
Purpose of the Study:
- To investigate the effects of diflunisal on platelet aggregation.
- To assess the clinical safety of diflunisal regarding bleeding.
- To evaluate diflunisal's efficacy in managing pain.
Main Methods:
- 15 patients and 5 healthy subjects received diflunisal (250 mg twice or thrice daily).
- Platelet aggregation was measured using adenosine diphosphate (ADP) and collagen.
- Measurements were taken before and during diflunisal treatment.
Main Results:
- Diflunisal demonstrated effectiveness in relieving musculo-skeletal pain.
- No significant adverse effects on platelet aggregation were observed.
- No instances of significant clinical bleeding were reported during the study.
Conclusions:
- Diflunisal is an effective analgesic for pain management.
- The studied dosage of diflunisal does not significantly impair platelet function.
- Diflunisal appears to have a favorable safety profile concerning bleeding risk.
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.